Replies to post #192225 on Cytodyn Inc (CYDY)

[theswordman]

They said they did. No 1 wants to believe it. Dr Patterson stated he also had funding lined up for longhauler trial. Guess we'll see. His LH trial will be without LL as the CCR5 antagonist. Doubt it works as well but they treated thousands of LHs. The people in on LL yell about the liver and blackbox--but it is not a longterm prescription. Just getting the symptoms/markers back to normal. Anything beats nothing for the suffering. Did anyone approach Dr Patterson about LL being in his LH trial. Of course everyone here laughed. Guess we'll see in JAN if our LH trial is actually approved. Still need a CRO/contract/approval.

I just don't buy--and will NEVER vote for 200 million shares. IF any of the "oh so close" that so many here brag about (BTD--LH--Brazil--BLA--ETC--ETC) are weeks away as stated then 20 million shares is WAY more than needed. Nodder doesn't have to tell how many vials are sold or any pricing. But he could be honest and discuss ACTUAL FACTUAL revenue.
200 million shares is just a random number--same as 25 million shares. With 25 million we can all see how they get used (or wasted) then there will be "more easy" or "no more bud". This millions and millions wasted and awarded has to stop. Long since 2015/16

[Black-Ops]

The way I see the 200,000,000 million vote issue to increase authorized is very simple.

1st, I do not listen to CC; gives me an advantage over any that do. If Nader said without that 200,000,000 we will close up shop is pure BULL.

Why?

2nd; The Next day, any decent CEO would declare a 1 new for 4 old or a 1 new for 10 old. Presto. Problem solved. The CEO's job is to protect the company. We need an asset to sell. Our shares? Our best bet.

Shareholders Current Account values? Wham, down 50% minimum.

Lets say a 1 for 10. Now we have roughly 80,000,000 common shares and warrants outstanding. BUT our authorized is 800,000,000 shares.

No one can shoot holes in this explanation.

Anyone actually observed such a move. I have.

This buys us time to run through the Brazil Trials and proove to the world what Leronlimab can do.

Post the first approval; we become a fundamental supported company.